You can buy or sell Oragenics and other stocks, options, ETFs, and crypto commission-free!
Oragenics Inc., also called Oragenics, is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. Read More The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
52 Week High
52 Week Low
Seeking AlphaMar 20
Oragenics -13.1% on proposed equity offering
Oragenics (NYSEMKT:OGEN) has slipped 13.1% after announcing a proposed equity offering. Terms weren't disclosed, but it will offer shares and warrants via H.C. Wainwright & Co. The underwriter will get a 30-day option to buy additional shares/warrants at the public offering price. Net proceeds will go to fund the AG013 research, clinical trials, preclinical development of the lantibiotics program, and general purposes....
Markets InsiderMar 20
Organics Announces Proposed Underwritten Public Offering
Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announced that it has commenced a proposed underwritten public offering of common stock of the Company, together with warrants to purchase shares of common stock. In addition, the Company expects to grant the underwriter of the offering, a 30-day option to purchase additional shares of common stock and/or warrants at the public offering price, l...
Markets InsiderMar 15
Oragenics, Inc. Announces Enrollment of 60th Patient in Clinical Trial
Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announces the enrollment of the 60th patient in its Phase 2 double blind, placebo controlled clinical trial of AG013 (NCT03234465). AG013 is an oral mouth rinse composed of a recombinant Lactococcus lactis bacteria strain that contains the coding sequence for human trefoil family factor 1 (hTFF1), which is continually secreted by the bacteria. ...
Expected Mar 25, After Hours